Russell Investments Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Sell |
61,095
-22,056
| -27% | -$615K | ﹤0.01% | 1799 |
|
|
2025
Q1 | $1.88M | Buy |
83,151
+83,126
| +332,504% | +$1.88M | ﹤0.01% | 1735 |
|
|
2024
Q4 | $495 | Sell |
25
-32
| -56% | -$634 | ﹤0.01% | 3611 |
|
|
2024
Q3 | $1.42K | Buy |
+57
| New | +$1.42K | ﹤0.01% | 3438 |
|
|
2023
Q4 | – | Sell |
-20,814
| Closed | -$363K | – | 3258 |
|
|
2023
Q3 | $363K | Buy |
+20,814
| New | +$363K | ﹤0.01% | 2332 |
|
|
2023
Q2 | – | Sell |
-31,639
| Closed | -$340K | – | 3495 |
|
|
2023
Q1 | $340K | Buy |
31,639
+8,025
| +34% | +$86.3K | ﹤0.01% | 2371 |
|
|
2022
Q4 | $354K | Buy |
23,614
+3,253
| +16% | +$48.7K | ﹤0.01% | 2409 |
|
|
2022
Q3 | $261K | Buy |
+20,361
| New | +$261K | ﹤0.01% | 2473 |
|
|
2022
Q1 | – | Sell |
-10,740
| Closed | -$126K | – | 2852 |
|
|
2021
Q4 | $126K | Sell |
10,740
-3,699
| -26% | -$43.4K | ﹤0.01% | 2806 |
|
|
2021
Q3 | $163K | Sell |
14,439
-250
| -2% | -$2.82K | ﹤0.01% | 2810 |
|
|
2021
Q2 | $204K | Sell |
14,689
-1,328
| -8% | -$18.4K | ﹤0.01% | 2904 |
|
|
2021
Q1 | $296K | Buy |
16,017
+13,817
| +628% | +$255K | ﹤0.01% | 2719 |
|
|
2020
Q4 | $38K | Hold |
2,200
| – | – | ﹤0.01% | 2945 |
|
|
2020
Q3 | $33K | Hold |
2,200
| – | – | ﹤0.01% | 3110 |
|
|
2020
Q2 | $56K | Hold |
2,200
| – | – | ﹤0.01% | 2979 |
|
|
2020
Q1 | $34K | Buy |
+2,200
| New | +$34K | ﹤0.01% | 2907 |
|